Free Trial
NASDAQ:IDXX

IDEXX Laboratories Q2 2025 Earnings Report

IDEXX Laboratories logo
$535.54 +1.23 (+0.23%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$535.86 +0.33 (+0.06%)
As of 08/1/2025 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IDEXX Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
$3.28
Beat/Miss
N/A
One Year Ago EPS
N/A

IDEXX Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.06 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

IDEXX Laboratories Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Monday, August 4, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

IDEXX Laboratories Earnings Headlines

Earnings Outlook For IDEXX Laboratories
IDEXX Laboratories Q2 2025 Earnings Preview
Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.
See More IDEXX Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IDEXX Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEXX Laboratories and other key companies, straight to your email.

About IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

View IDEXX Laboratories Profile

More Earnings Resources from MarketBeat